Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology
Incidence of Niemann-Pick disease type C
13 evidence topics · 11 sources
Guideline incidence estimate and range across national studies
“Statement #2: NPC disease is ultra‐rare, with an estimated incidence of one case per 100 000 live births.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The disease is pan‐ethnic, with at least 95% of all cases attributed to variants in NPC1, and the remainder in NPC2.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The milder forms of the disease remain underdiagnosed.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Retrospective, national expert center‐based studies from Australia, the Netherlands, the UK, Portugal, the Czech Republic, France, and the United Arab Emirates have reported an annual incidence varying between 0.25 and 2.20 per 100 000 live births” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Incidence predicted from exome sequencing data sets
“We determined a combined incidence of classical NPC of 1/89,229 or 1.12 affected patients per 100,000 conceptions, but predict incomplete ascertainment of a lateonset phenotype of NPC1.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Our data suggests an incidence rate for NPC1 and NPC2 of 1/92,104 and 1/2,858,998, respectively.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“However, evaluation of common NPC1 variants, suggests that there may be a late-onset NPC1phenotype with a markedly higher incidence on the order of 1/20,000–39,000.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Incidence in France
Minimal incidence and birth prevalence by country
“Niemann-Pick C disease (NP-C) is a neurovisceral atypical lysosomal lipid storage disorder with an estimated minimal incidence of 1/120 000 live births.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Estimates of birth prevalence ranging between 0.66 and 0.83 per 100,000 were proposed for France, the UK and Germany based on diagnoses made in the laboratory of the author over the period 1988-2002” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Birth prevalence by country and in Quebec
“Elsewhere in the world, the prevalence of NP-C for 100,000 live births is 0.47 in Australia44, 0.91 in Czech Republic15, 2.2 in Northern Portugal4, 0.35 in the Netherlands3, 0.82 for France5, 0.78 for the United Kingdom45 and 1.12 for the United States of America (USA)46.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“By combining these different prevalences, we obtain an average of 0.95 cases per 100,000 births.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“We estimate a prevalence of 0.61 per 100,000 births in Quebec.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Estimated new cases per year in the United States
Distribution of clinical forms in eight national and international cohorts
Regional variation in the early infantile form
“Two features emerge from the compiled data presented in Table 1: the early infantile neurological onset form appears more frequent in Southern Europe and the Middle East, and patients with the adult‐onset neurological form seem to represent at least 20% of the cases of NPC and, owing to their longer survival, probably constitute the largest patient group in terms of disease prevalence” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Distribution by age at neurological onset: International Niemann-Pick Disease Registry
“A total of 203 NPC patients from six European countries were included in this study.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Among enrolled patients, 168 had known neurological manifestations: 43 (24.2%) had early-infantile onset, 47 (26.4%) had late-infantile onset, 41 (23.0%) had juvenile onset, and 37 (20.8%) had adult onset.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“10 (5.6%) patients had the neonatal rapidly fatal systemic form.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Distribution by age at neurological onset: pooled national cohorts and NPC Registry
“Data for 789 patients from five large national cohorts and from the NPC Registry were collected and combined.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The Neurological onset group comprised 97 early infantile, 210 late infantile, 198 juvenile, and 163 adolescent/adult patients (Table 1).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Distribution by age at neurological onset: NPC Registry at closure
“At database closure, 472 patients from 22 countries were enrolled in the NPC Registry (see Additional file 1), with a similar proportion of males (n = 245; 51.9%) and females (n = 227; 48.1%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Patients with known age at onset of neurological symptoms (n = 422) were categorized as early-infantile (n = 57; 13.5%), late-infantile (n = 108; 25.6%), juvenile, (n = 134; 31.8%), or adolescent/adult (n = 123; 29.1%) onset (Table 2).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Early infantile neurological onset among patients diagnosed in France, 1990 to 2013
“During the period 1990–2013, a total of 153 new patients with NP-C (from perinatal period to adulthood) were diagnosed in France, among which 32 patients (21%) with neurological onset before 2 years of age, who were thus classified as suffering from the EI neurological form of the disease.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote